TCR V β8+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease

Journal of Immunology

Volumn 170, Issue 8, 2003, Pages 4254-4259

  Kang, Hoil ^a,b,d   Liesenfeld, Oliver ^a,b,e   Remington, Jack S ^a,b   Claflin, Jennifer ^c   Wang, Xisheng ^c   Suzuki, Yasuhiro ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PALO ALTO MEDICAL FOUNDATION   (United States)

^c VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^d Department of Internal Medicine   (Japan)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR VBETA8; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL POPULATION; CELL TRANSFER; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; GENETIC RESISTANCE; IMMUNOCOMPETENT CELL; LYMPHOCYTIC INFILTRATION; MORTALITY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE; TOXOPLASMA GONDII;

EID: 0037446524     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.8.4254     Document Type: Article

References (33)

1. Fabry, Z., C. S. Raine, and M. N. Hart. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:218.
2. Owens, T., T. Renno, V. Taupin, and M. Krakowski. 1994. Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunol. Today 15:566.
3. Engelhardt, B., M. T. G. Martin-Simonet, L. S. Rott, E. C. Butcher, and S. A. Michie. 1998. Adhesion molecule phenotype of T lymphocytes in inflamed CNS. J. Neuroimmunol. 84:92.
4. Israelski, D. M., and J. S. Remington. 1993. Toxoplasmosis in the non-AIDS immunocompromised host. Curr. Clin. Top. Infect. Dis. 13:332.
5. Wong, S. Y., and J. S. Remington. 1994. Toxoplasmosis in the setting of AIDS. In Text Book of AIDS Medicine. S. Broder, T. C. Merigan, Jr., and D. Bolognesi, eds. Williams and Wilkins, Baltimore, p. 223.
6. Suzuki, Y. 2000. Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis. Immunobiology 201:255.
7. Hunter, C. A., and J. S. Remington. 1994. Immunopathogenesis of toxoplasmic encephalitis. J. Infect. Dis. 170:1057.
8. Yap, G., and A. Sher. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen Toxoplasma gondii. J. Immunol. 165:628.
9. Brown, C. R., C. S. David, S. J. Khare, and R. McLeod. 1994. Effects of human class I transgenes on Toxoplasma gondii cyst formation. J. Immunol. 152:4537.
10. Deckert-Schlüter, M., H. Bluethman, N. Kaefer, A. Rang, and D. Schlüter. 1999. Interferon-γ receptor-mediated but not tumor necrosis factor receptor type-1 or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. Am. J. Pathol. 154:1549.
11. + T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host. Infect. Immun. 67:5869.
12. Suzuki, Y., S. W. Wong, F. C. Grumet, J. Fessel, J. G. Montoya, A. R. Zolopa, A. Portimore, F. Schumacher-Perdeau, M. Schrappe, S. Koppen, et al. 1996. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J. Infect. Dis. 173:265.
13. Mack, D. G., J. J. Johnson, F. Roberts, C. W. Roberts, R. G. Estes, C. David, F. C. Grumet, and R. McLeod. 1999. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int. J. Parasitol. 29:1351.
14. d region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732.
15. Brown, C. R., C. A. Hunter, R. G. Estes, E. Beckmann, J. Forman, C. David, J. S. Remington, and R. McLeod. 1995. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419.
16. Suzuki, Y., K. Joh, O.-C. Kwon, Q. Yang, F. K. Conley, and J. S. Remington. 1994. MHC class I gene(s) in the D/L region but not the TNF-α gene determines development of toxoplasmic encephalitis in mice. J. Immunol. 15:4649.
17. Suzuki, Y., M. A. Orellana, S.-Y. Wong, F. K. Conley, and J. S. Remington. 1993. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection. Infect. Immun. 61:2284.
18. Johnson, J., Y. Suzuki, D. Mack, E. Mui, R. Estes, C. David, E. Skemene, J. Forman, and R. McLeod. 2002. Genetic analysis of influences on survival following Toxoplasma gondii infection. Int. J. Parasitol. 32:179.
19. Kang, H., and Y. Suzuki. 2001. Requirement of non-T cells that produce interferon-γ for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect. Immun. 69:2920.
20. Suzuki, Y., S. Rani, O. Liesenfeld, T. Kojima, S. Lim, T. A. Nguyen, S. A. Dalrymple, R. Murray, and J. S. Remington. 1997. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect. Immun. 65:2339.
21. Suzuki, Y., Q. Yang, S. Yang, N. Nguyen, S. Lim, O. Liesenfeld, T. Kojima, and J. S. Remington. 1996. IL-4 is protective against development of toxoplasmic encephalitis. J. Immunol. 157:2564.
22. Conley, F. K., K. A. Jenkins, and J. S. Remington. 1981. Toxoplasma gondii infection of the central nervous system: use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin-fixed paraffin embedded tissue section. Hum. Pathol. 12:690.
23. Suzuki, Y., F. K. Conley, and J. S. Remington. 1989. Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii. J. Infect. Dis. 159:790.
24. Suzuki, Y., H. Kang, S. Parmley, S. Lim, and J. S. Remington. 2000. Induction of tumor necrosis factor-α and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-γ in genetically resistant BALB/c mice. Microbes Infect. 2:455.
25. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
26. Nakano, Y., H. Hisaeda, T. Sakai, H. Ishikawa, M. Zhang, Y. Maekawa, T. Zhang, M. Takahashi, M. Nishitani, R. A. Good, and K. Himeno. 2002. Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages. Microbes Infect. 4:1.
27. Li, H., A. Llera, and R. A. Mariussa. 1998. Structure-function studies of T-cell receptor-superantigen interactions. Immunol. Rev. 163:177.
28. Tomonari, K., S. Fairchild, and O. A. Rosenwasser. 1993. Influence of viral superantigens on Vβ- and Vα-specific positive and negative selection. Immunol. Rev. 131:131.
29. + lymphocytes. J. Exp. Med. 180:985.
30. Denkers, E. Y., P. Casper, and A. Sher. 1996. Toxoplasma gondii infection induces specific nonresponsiveness in lymphocytes bearing Vβ5 chain of the mouse T cell receptor. J. Immunol. 156:1089.
31. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393.
32. Kang, J. A., M. Mohindru, B. S. Kang, S. H. Park, and B. S. Kim. 2000. Clonal expansion of infiltrating T cells in the spinal cords of SJL/J mice infected with Theiler's virus. J. Immunol. 165:583.
33. Gorgette, O., A. Existe, M. I. Boubou, S. Bagot, J. L. Guenet, D. Mazier, P. A. Cazenave, and S. Pied. 2002. Deletion of T cells bearing the Vβ8.1 T-cell receptor following mouse mammary tumor virus 7 integration confers resistance to murine cerebral malaria. Infect. Immun. 70:3701.